# Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast acquisitions

Fagron, a global pharmaceutical compounding company, announced that Brazilian competition authority CADE has granted clearance for the acquisitions of Purifarma and Injeplast in Brazil. The transactions will broaden Fagron's portfolio and capabilities in Brazil.

- Type: Acquisition
- Announced: 2025-10-06
- Where: Brazil
- Status: announced
- Products: pharmaceutical compounding, packaging solutions
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Fagron](https://endata.com/companies/87680.md) (acquirer)
- [Purifarma](https://endata.com/companies/87681.md) (target)
- [Injeplast](https://endata.com/companies/87682.md) (target)

## Sources

- [menafn.com](https://menafn.com/1110153834/Fagron-Receives-Brazilian-Antitrust-Clearance-For-Purifarma-And-Injeplast-Acquisitions), 2025-10-06: "CADE's approvals allow us to progress towards closing Purifarma and Injeplast."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.